Preliminary results of a phase II trial on targeted therapy with cetuximab in EGFR-expressing adenoid cystic carcinoma of the oral cavity

被引：0
|
作者：
Hitre, Erika [1 ]
Boer, Andras [1 ]
Remenar, Eva [1 ]
Takacsi-Nagy, Zoltan [1 ]
Godeny, Maria [1 ]
Kasler, Miklos [1 ]
Lang, Istvan [1 ]
机构：
[1] Natl Inst Oncol, Budapest, Hungary
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [1] The Phase I/II ACCEPT Trial: Cetuximab and IMRT with Carbon Ion Boost for Adenoid Cystic Carcinoma
    Adeberg, S.
    Jensen, A.
    Akbaba, S.
    Katayama, S.
    Verma, V.
    Bernhardt, D.
    Nikoghosyan, A.
    Abollahi, A.
    Plinkert, P.
    Rieken, S.
    Muenter, M.
    Juergen, D.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 90 - 90
  • [2] Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial
    Hitre, E.
    Budai, B.
    Takacsi-Nagy, Z.
    Rubovszky, G.
    Toth, E.
    Remenar, E.
    Polgar, C.
    Lang, I.
    BRITISH JOURNAL OF CANCER, 2013, 109 (05) : 1117 - 1122
  • [3] A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer
    Do, Khanh
    Cao, Liang
    Kang, Zhigang
    Turkbey, Baris
    Lindenberg, Maria L.
    Larkins, Erin
    Holkova, Beata
    Steinberg, Seth M.
    Raffeld, Mark
    Peer, Cody J.
    Figg, William D.
    Eugeni, Michelle
    Jacobs, Paula
    Choyke, Peter
    Wright, John J.
    Doroshow, James H.
    Kummar, Shivaani
    CLINICAL COLORECTAL CANCER, 2015, 14 (03) : 154 - 161
  • [4] Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial
    Hoover, Andrew C.
    Milhem, Mohammed M.
    Anderson, Carryn M.
    Sun, Wenqing
    Smith, Brian J.
    Hoffman, Henry T.
    Buatti, John M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (05): : 722 - 726
  • [5] Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
    Wong, S. J.
    Karrison, T.
    Hayes, D. N.
    Kies, M. S.
    Cullen, K. J.
    Tanvetyanon, T.
    Argiris, A.
    Takebe, N.
    Lim, D.
    Saba, N. F.
    Worden, F. P.
    Gilbert, J.
    Lenz, H. J.
    Razak, A. R. A.
    Roberts, J. D.
    Vokes, E. E.
    Cohen, E. E. W.
    ANNALS OF ONCOLOGY, 2016, 27 (02) : 318 - 323
  • [6] Preliminary Results of a Phase II Trial with Proton Beam Therapy for Nasopharyngeal Carcinoma
    Wear, C.
    Wang, J.
    Truong, M.
    Liebsch, N.
    Busse, P.
    Clark, J.
    Chan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S422 - S423
  • [7] Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy
    Dorjsuren, Buyankhishig
    Chaurasiya, Birendra
    Ye, Zixuan
    Liu, Yanyan
    Li, Wei
    Wang, Chaoyang
    Shi, Di
    Evans, Colin E.
    Webster, Thomas J.
    Shen, Yan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 8201 - 8215
  • [8] Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
    Thomson, David J.
    Silva, Priyamal
    Denton, Kim
    Bonington, Suzanne
    Mak, Soo K.
    Swindell, Ric
    Homer, Jarrod
    Sykes, Andrew J.
    Lee, Lip W.
    Yap, Beng K.
    Slevin, Nicholas J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (02): : 182 - 187
  • [9] Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma
    Ferrarotto, Renata
    Sousa, Luana G.
    Feng, Lei
    Mott, Frank
    Blumenschein, George
    Altan, Mehmet
    Bell, Diana
    Bonini, Flavia
    Li, Kaiyi
    Marques-Piubelli, Mario L.
    Dal Lago, Eduardo A.
    Johnson, Jason J.
    Mitani, Yoshitsugu
    Godoy, Myrna
    Lee, Anna
    Kupferman, Michael
    Hanna, Ehab
    Glisson, Bonnie S.
    Elamin, Yasir
    El-Naggar, Adel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2843 - +
  • [10] The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck
    Adeberg, Sebastian
    Akbaba, Sati
    Lang, Kristin
    Held, Thomas
    Verma, Vivek
    Nikoghosyan, Anna
    Bernhardt, Denise
    Muenter, Marc
    Freier, Kolja
    Plinkert, Peter
    Hauswald, Henrik
    Herfarth, Klaus
    Rieken, Stefan
    Debus, Juergen
    Jensen, Alexandra Desire
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (01): : 167 - 173
12345